# Treating Schizophrenic Smokers: Effects on Craving, Cues and Withdrawal

> **NCT00781755** · PHASE4 · WITHDRAWN · sponsor: **VA Boston Healthcare System**

## Conditions studied

- Tobacco Use Disorder

## Interventions

- **DRUG:** varenicline
- **BEHAVIORAL:** Adaptation of Motivational Interviewing

## Key facts

- **NCT ID:** NCT00781755
- **Lead sponsor:** VA Boston Healthcare System
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study design was altered such that a treatment component was removed through the VA IRB. We did not and will not begin this clinical trial.
- **Last updated:** 2015-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00781755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00781755, "Treating Schizophrenic Smokers: Effects on Craving, Cues and Withdrawal". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00781755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*